Six in 10 pet owners reveal they prefer to spend time with their pets when feeling stressed, according to new survey
Six out of 10 (58%) pet owners reveal they prefer to spend time with their pets when feeling stressed. Putting pets ahead of partners, family, children or friends
A new global survey of over 30,000 pet owners conducted by Mars and Calm uncovers the many ways pet cats and dogs impact our daily wellbeing
From being the go-to companion in a moment of stress to nudging people to take more breaks, pets are quietly helping us be more zen
Pets are even encouraging us to take breaks from activities that can fuel our stress – from doomscrolling, chores, work and other tasks
And while for many it's the silent support they value, 77% find talking to their pets relaxing
Mars and Calm are teaming up to celebrate the special bond with pets through a series of pet-inspired content for pet lovers, set to go live during Mental Health Awareness Month in the US and Mental Health Awareness Week in the UK
BRUSSELS, May 13, 2025 /CNW/ -- If you would rather hug your pet than talk to your partner after a stressful day then you're not alone. A new global survey of over 30,000 pet owners, (1) commissioned by Mars, the leading pet care business, and Calm, a leading mental health company, found that the majority of pet owners (58%) prefer to spend time with their pet when feeling stressed – more than those who say their partners (32%), family (23%), or even children or friends (both 18%). In fact, 83% of people surveyed believe their pet has positively impacted their mental wellbeing.
The global survey across 20 markets highlights the powerful ways our pets improve our mental health and wellbeing. From encouraging us to switch off in our day-to-day with breaks from screens, work and chores, to offering silent comfort when words feel too much, the findings paint a striking picture of how pets are helping millions of people around the world find peace in an always-on world.
Pets: the silent wellbeing guides always by our side
Sometimes, it's not what they do – it's just that they are there. More than half of pet owners (56%) say their pets provide company without the need to talk during stressful times. While others find chatting to their pet a help – with nearly a quarter (23%) saying their pet provides a space for them to express worries or concerns without expecting a response. A huge 84% of pet owners say the simple presence of their pet is relaxing, offering a sense of calm that doesn't require words or actions.
"While we love our pets, we often don't realise how much they give back," said Dr. Tammie King, a specialist in human-animal interaction and Senior Research Manager at the Waltham Petcare Science Institute." Reframing your pet's daily 'interruptions' as loving reminders to pause, breathe and be present can be a powerful wellness tool. Research shows that touch-based pet interactions can boost oxytocin levels in humans. (2) The findings of this survey will help more people reflect on and acknowledge the little wellbeing moments pets nudge us towards on a daily basis."
A look, wag or a boop: the survey also reveals how our pets' behaviours give us daily nudges towards better wellbeing habits:
Stepping away from the daily grind: Almost eight in 10 (78%) say their pet reminds them to pause and take a break from work, chores or tasks, with 50% saying this happens daily – a gentle reminder to stop, breathe and reset
Calming the mind: 73% of owners say their pet encourages them to stop overthinking or worrying – helping them feel calmer and more centred
Time in the great outdoors: 73% of pet owners say their pet encourages them to spend time outside, turning walks with a pet into wellbeing
Even screens take a backseat when pets are around: 77% say their pet encourages them to take a break away from screens – and for half (50%) it's a daily reminder to unplug, a vital counter to constant scrolling and digital burnout
Dr. Chris Mosunic, Chief Clinical Officer at Calm said: " We know that small, intentional moments of calm can have a big impact on our overall wellbeing, and our pets have an incredible way of guiding us there. A quick dog walk, or cat cuddle at our desk when they stroll in front of the screen, can provide a simple moment to reset and recharge. We're proud to partner with Mars and bring this data to the forefront to highlight the potential of our bond with pets and help more people discover the wonderful wellbeing benefits our relationship with pets can bring."
The survey marks the launch of a first-of-its-kind partnership between Mars and Calm which aims to explore and celebrate the deep connection between people and pets as a force for everyday wellbeing. Turning insight into action, Mars and Calm have teamed up to create new content to help support wellbeing while nurturing the bond with your pet. The Mars x Calm content collection is a series of pet-inspired content to help you relax, reflect and recharge. This is Calm's first collection created just for pet lovers and inspired by the mutual relationship between people and their pets.
To celebrate the partnership, Mars and Calm are launching a social search to find touching stories from pet owners of their pets that showcase the power of the human-animal bond. Pet owners have the chance for their pets' story to become the inspiration for exclusive Calm content later this year.*
As part of this search, Mars and Calm are launching My Pet Guru – an interactive quiz available on Kinship. The tool identifies one of six pet wellbeing superpowers based on responses to five simple questions, designed to help pet owners recognise and celebrate the unique ways their pets support emotional and mental wellbeing.
For more information on the Mars x Calm partnership, visit: kinship.com/petsandwellbeing
References
(1) The research was conducted by YouGov Plc on behalf of Mars. Total sample size was 31299 adults across 20 markets (UK: 2507, Brazil: 2502; Canada: 1347; Germany: 1584; Indonesia: 2510; India: 1001; Mexico: 1567; Malaysia: 1036; Poland: 1349; US: 3748; China: 1054: Belgium: 1084; Australia: 1525; New Zealand: 1066; Spain: 1322; Netherlands: 1074; France: 1526; Denmark: 1093; Sweden: 1070; Italy: 1334). Fieldwork was undertaken between 19th February - 31st March 2025. The survey was carried out online. The figures have been weighted at an individual country level to be representative of all dog and cat owners (aged 18+) in the respective markets.
(2) Oxytocin, Children and Dogs | WALTHAM
*Participating markets only (US, UK, Australia), T&Cs on kinship.com/petsandwellbeing
About Mars, Incorporated
Mars, Incorporated is driven by the belief that the world we want tomorrow starts with how we do business today. As a $50bn+ family-owned business, our diverse and expanding portfolio of leading pet care products and veterinary services support pets all around the world and our quality snacking and food products delight millions of people every day. We produce some of the world's best-loved brands including ROYAL CANIN®, PEDIGREE®, WHISKAS®, CESAR®, DOVE®, EXTRA®, M&M's®, SNICKERS® and BEN'S ORIGINAL™. Our international networks of pet hospitals, including BANFIELD™, BLUEPEARL™, VCA™, ANICURA™ and LINNAEUS span preventive, general, specialty, and emergency veterinary care, and our global veterinary diagnostics business ANTECH® offers breakthrough capabilities in pet diagnostics. The Mars Five Principles — Quality, Responsibility, Mutuality, Efficiency and Freedom — inspire our 150,000 Associates to act every day to help create a better world for people, pets and the planet.
For more information about Mars, please visit www.mars.com. Join us on Facebook, Instagram, LinkedIn and YouTube.
For more information on the PAWS program, visit: https://www.mars-petsandwellbeing.com.
About Calm
Calm is a leading consumer mental health company on a mission to support everyone on every step of their mental health journey. Known for its flagship consumer app—ranked #1 in its category with over 180 million downloads and available in seven languages across 190 countries—Calm helps people sleep better, stress less, and live more mindfully through content and tools from experts and beloved celebrity voices. Building on this foundation, Calm has created a broader portfolio including evidence-based solutions like Calm Health, offered through employers and health plans, designed to expand access to mental health and sleep support, boost benefits engagement, and drive positive health outcomes. Today, Calm supports more than 3,500 organizations and reaches over 15 million covered lives through Calm Health. Calm has been recognized as a TIME100 Most Influential Company and one of Fast Company's Brands That Matter.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
2 hours ago
- Cision Canada
THE FIRST NATIONS HEALTH MANAGERS ASSOCIATION TO LEAD MULTI-YEAR INDIGENOUS HEALTH NAVIGATORS (IHN) TRAINING AND CURRICULUM DEVELOPMENT INITIATIVE
OTTAWA, ON, /CNW/ - The First Nations Health Managers Association (FNHMA) is leading a multi-year project focused on developing a comprehensive training and curriculum program for Indigenous Health Navigators (IHN). IHNs have been recognized as essential roles within the Indigenous health system workforce. These professionals possess a deep understanding of the complex jurisdictional health landscape and the historical and current realities faced by First Nations patients and families. IHNs provide culturally safe and trauma-informed support, acting as vital bridges between community-based health services and the mainstream health systems often accessed in urban settings. Through this initiative, FNHMA will support the development of a national network by identifying and establishing standardized competencies that reflect the diverse skill set of the current workforce. These competencies are intended to complement the work of First Nations Health Managers and strengthen the overall health management framework within First Nations communities. Building on previous foundational work, the project will assess the existing landscape of the IHN role, propose a vision for its future evolution, and identify best practices and accredited training opportunities. Additionally, the initiative will focus on the development of core competencies, curriculum, and instructional materials, while delivering an actionable implementation plan to meet workforce needs and enhance career pathways for IHN. This initiative reflects FNHMA's ongoing commitment to capacity building and the advancement of Indigenous-led health services. As always, FNHMA's approach is grounded in engagement with its' members and partners whose knowledge and lived experience is instrumental in guiding the project's direction. FNHMA is pleased to announce that Dr. Pamela Toulouse has been appointed as the Lead Consultant for this initiative. Dr. Toulouse is a respected educator, researcher, and advocate with extensive experience in Indigenous health, education, and community empowerment.
Cision Canada
10 hours ago
- Cision Canada
Approved by Health Canada - Zilia Ocular: A World First Set to Revolutionize Eye Care
QUEBEC CITY, June 19, 2025 /CNW/ - Zilia, a Canadian health technology company, is proud to announce that its flagship product, the Zilia Ocular™, has received approval from Health Canada. It is the first device in the world authorized to measure oxygen saturation in the eye—a breakthrough that has the potential to redefine eye care. Developed in Quebec City, the Zilia Ocular is a revolutionary retinal camera equipped with a patented optical technology that enables the non-invasive measurement of oxygenation in the eye. This metabolic biomarker gives eye care professionals an entirely new window into the physiological state of the eye, with the goal of detecting issues well before structural damage occurs. "This represents a true paradigm shift," said Dr. Patrick Sauvageau, optometrist, CEO and co-founder of Zilia. "By measuring retinal oxygenation in real time, we aim to help clinicians detect and manage eye diseases such as glaucoma, diabetic retinopathy, and age-related macular degeneration more effectively." A Breakthrough at the Heart of Oculomics As oculomics—an emerging field that uses the eye as a gateway to assess overall health—gains traction globally, biomarkers like oxygen saturation are paving the way for a more preventive, personalized, and data-driven approach to medicine. The Zilia Ocular is at the forefront of this movement, introducing a layer of analysis that was previously inaccessible in clinical settings. Zilia plans to launch its device in Canada in the coming months, followed by expansion into the United States and Europe. About Zilia Zilia is a health technology company developing a groundbreaking platform to non-invasively measure biomarkers in the eye, with an initial focus on ocular oximetry. By integrating advanced photonics and artificial intelligence, Zilia's first-of-kind technology is intended to leverage the eye's optical properties and direct connections to the vascular system and the brain to capture critical information on ocular and overall health.
Cision Canada
11 hours ago
- Cision Canada
Chronic Conditions Collide: The Rising Complexity of Long-Term Disability Claims Français
Sun Life data shows many Canadians on disability are living with more than one chronic health condition TORONTO, June 19, 2025 /CNW/ - The latest report in Sun Life's Designed for Health series reveals a troubling trend in long-term disability (LTD) claims among Canadians. Mental disorders, circulatory disorders and cancer are the top three reasons for LTD, but their claims don't stop there. Employees on disability leave are increasingly struggling with multiple, overlapping health disorders, making their LTD claim more complex. Multiple chronic conditions (known as "comorbidities" or "multiple morbidities") have become more common among Canadians. Sun Life looked at the drug claims data from over 1.5 million people on LTD and found: Diabetes, mental disorders and cardiovascular conditions are among the top drug claims to treat a secondary condition. Members on LTD are two times more likely to claim for a chronic disease drug related to a secondary condition than those not on LTD. They are three times more likely to claim for chronic disease drugs, treating two or more conditions in addition to their primary LTD claim. Diabetes is a common thread throughout many LTD claims and illustrates how chronic health conditions are overlapping: Plan members on LTD leave are almost three times more likely to have a diabetes drug claim than others. Drug claims for diabetes are up 30% from 2019 to 2023 across all claimants, not just LTD. "Long-term disability claims are often complex and our data tells us that Canadians, more than ever, are struggling when it comes to their health and well-being," says Marie-Chantal Côté, Senior Vice-President, Sun Life Health. "Dealing with multiple chronic conditions can be challenging and requires a holistic and comprehensive approach to recovery. As a trusted health partner to millions of Canadians and their families, our mission is to empower our members with personalized solutions, ensuring easier access to the care they need." Supporting Employees on LTD to Return to Work The presence of two or more health issues often worsens the primary condition and makes disease management more complicated. This can mean a long and difficult road to recovery. Those with comorbidities often see a delay in returning to work and remain on claim for longer than the average claim. "The road to recovery looks different for everyone. When helping an employee return to health, it's important we look at the full picture of their health, from comorbidities to personal stressors, to come up with a treatment plan that is right for them," says Côté. "We take an empathic approach to care that helps employees regain a sense of normalcy." Sun Life takes a holistic approach to supporting our plan members. Some of the innovative health solutions we offer include: Psychosocial Questionnaire – Sun Life's innovative new tool allows case managers to gain a deeper understanding of plan member health. The questionnaire helps identity case complexity and ensures members get the timely, additional support and treatments they need. Medical Confidence – Through our partnership with Kii Health, Medical Confidence is offered to our members to enhance disability claim support by offering timely access to specialist care, saving plan members an average of 317 wait days for specialist appointments. 1 Pharmacogenomic testing – Allows plan members to find the right drug treatment faster by potentially eliminating or reducing the trial-and-error process of finding the right medication. Read the 2025 Designed for Health Report to learn more about the trends in long-term disability claims in Canada. About Sun Life Sun Life is a leading international financial services organization providing asset management, wealth, insurance and health solutions to individual and institutional Clients. Sun Life has operations in a number of markets worldwide, including Canada, the U.S., the United Kingdom, Ireland, Hong Kong, the Philippines, Japan, Indonesia, India, China, Australia, Singapore, Vietnam, Malaysia and Bermuda. As of March 31, 2025, Sun Life had total assets under management of $1.55 trillion. For more information, please visit Sun Life Financial Inc. trades on the Toronto (TSX), New York (NYSE) and Philippine (PSE) stock exchanges under the ticker symbol SLF. Note to editors: All figures in Canadian dollars To contact Sun Life media relations, please email [email protected].
